Effects of Shilajit (Momiai) on COVID-19 disease
Phase 3
Recruiting
- Conditions
- COVID-19.COVID-19, virus identifiedU07.1
- Registration Number
- IRCT20210508051225N1
- Lead Sponsor
- Gonabad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 110
Inclusion Criteria
Diagnosis of moderate COVID-19 disease (based on the World Health Organization laboratory and clinical criteria)
Receiving standard and routine medications for moderate COVID-19 based on management protocols for COVID-19
age between 18 and 75 years old
signing the written informed consent form
Exclusion Criteria
Pregnancy
Lactation
Immune deficiency conditions (receiving chemotherapy, organ or bone marrow transplantation, autoimmune diseases)
History of chronic pulmonary disease
Participating or being registered for other trials
Severe renal failure (GFR< 30ml/min)
Liver failure
Heart failure (EF<40%)
History underlying diseases including diabetes and hypertension
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method